Latest Generic drug Stories
CE Class Focuses on Fundamentals of Biosimilars EAST ELMHURST, N.Y., March 16, 2015 /PRNewswire/ -- With the U.S.
DUBLIN, March 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has granted AstraZeneca's request for an injunction
POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Mylan Inc. today announced the U.S.
LOS ANGELES, March 10, 2015 /PRNewswire/ -- The Made in the USA Foundation filed a complaint with the U.S.
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)
DUBLIN, March 4, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey has found that United States Patent Nos.
DUBLIN, Feb. 24, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
DALLAS, February 22, 2015 /PRNewswire/ -- MarketReportsHub.com adds The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts research
MUMBAI, February 20, 2015 /PRNewswire/ -- A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product that is manufactured
- Large; stout; burly.